Does APREPITANT Cause Acute generalised exanthematous pustulosis? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Acute generalised exanthematous pustulosis have been filed in association with APREPITANT (CINVANTI). This represents 0.3% of all adverse event reports for APREPITANT.
16
Reports of Acute generalised exanthematous pustulosis with APREPITANT
0.3%
of all APREPITANT reports
0
Deaths
16
Hospitalizations
How Dangerous Is Acute generalised exanthematous pustulosis From APREPITANT?
Of the 16 reports, 16 (100.0%) required hospitalization.
Is Acute generalised exanthematous pustulosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Acute generalised exanthematous pustulosis?
VANCOMYCIN (417)
AMOXICILLIN (408)
CLINDAMYCIN (330)
ACETAMINOPHEN (321)
SULFAMETHOXAZOLE\TRIMETHOPRIM (285)
CEFTRIAXONE (261)
IBUPROFEN (258)
PIPERACILLIN\TAZOBACTAM (257)
ENOXAPARIN (251)
VALACYCLOVIR (239)
Which APREPITANT Alternatives Have Lower Acute generalised exanthematous pustulosis Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL